P2X7 antagonist (Lead Discovery)

N/A

Report date: 2025/03/20 09:58:39
NME

Base Information

Drug NameP2X7 antagonist (Lead Discovery)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionP2X purinoceptor 7 antagonists
TargetsP2X purinoceptor 7
Therapy Area/IndicationsNeuralgiaEpilepsyMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLead Discovery Center GmbH
China Registration ClassN/A

Develop Information

Active CompaniesLead Discovery Center GmbH
Inactive CompaniesN/A
Active IndicationsEpilepsyMultiple Sclerosis
Inactive IndicationsNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A